FSD stands for female sexual dysfunction, a broad medical term covering persistent problems with desire, arousal, orgasm, or pain during sex that cause personal distress. About 40% of women worldwide report some form of sexual difficulty, though roughly 12%, or one in eight, experience a level that causes significant distress or relationship problems. FSD is not a single condition but a category that includes several distinct disorders, each with different causes and treatments.
The Four Types of FSD
Medical guidelines divide FSD into four broad categories: low desire, low arousal, orgasmic dysfunction, and sexual pain. These align with the formal psychiatric classifications, but they often overlap in practice.
- Low desire means a persistent reduction or absence of sexual fantasies and interest in sexual activity. When this causes marked distress, it may be diagnosed as hypoactive sexual desire disorder (HSDD).
- Low arousal involves decreased physical response during sexual activity, such as reduced lubrication or diminished genital sensation related to blood flow.
- Orgasmic dysfunction refers to consistently delayed or absent orgasms despite adequate stimulation.
- Sexual pain includes pain at the vulva, deep pain during penetration, or involuntary tightening of the pelvic muscles that makes penetration difficult or impossible. This is formally called genito-pelvic pain/penetration disorder.
A key part of any FSD diagnosis is distress. Lower interest in sex as you age, for instance, is not considered a medical condition unless it bothers you or creates interpersonal difficulty.
What Causes It
FSD rarely has a single cause. It typically involves a mix of biological, psychological, and relationship factors that feed into each other.
On the biological side, sex hormones like estrogen, progesterone, and testosterone shape sexual desire and physical response by interacting with brain chemicals. Dopamine and norepinephrine drive the excitatory side of sexual function: dopamine boosts desire and excitement, while norepinephrine supports arousal and orgasm. Serotonin works in the opposite direction. Too much serotonin activity can suppress libido and reduce desire, which is why antidepressants that raise serotonin levels commonly cause sexual side effects.
Psychological contributors are just as important. Depression has a particularly strong link: research has found low sexual interest in 61% of people with severe depression, compared with 27% of those without depression. Anxiety can interfere with arousal directly, because worry about sexual performance is the opposite of the mental state needed for arousal. Body image concerns, damaged sexual self-confidence, stress from work or finances, and relationship conflict all act as maintaining factors that can keep sexual problems going long after the original trigger has passed.
Past experiences also matter. Women diagnosed with sexual pain disorders are more likely to have a history of sexual, physical, or emotional abuse. Even in otherwise resilient women, repeated negative sexual experiences can generate lasting dysfunction.
Menopause and Sexual Function
Menopause is one of the most common biological triggers for FSD. As hormone levels drop, vaginal tissue becomes thinner and drier, a condition called vaginal atrophy. This can make sex uncomfortable or painful, and many women also notice it takes longer to become aroused. Lower hormone levels can directly reduce sex drive as well. These changes are common and treatable, but they are only considered a medical issue if they cause you distress.
How FSD Is Diagnosed
There is no blood test or scan for FSD. Diagnosis relies on a detailed medical and psychosocial history, along with standardized questionnaires. The most widely used screening tool is the Female Sexual Function Index (FSFI), a 19-item questionnaire that measures six domains: desire, arousal, lubrication, orgasm, satisfaction, and pain. A total score below roughly 26.5 generally indicates sexual dysfunction, though the exact cutoff can vary by population. The FSFI helps clinicians identify which specific areas are affected and how severe the problem is.
Because so many factors can contribute, a thorough evaluation typically looks at medications you take (especially antidepressants), hormone status, mental health history, relationship dynamics, and any history of trauma.
Treatment Options
Treatment depends on which type of FSD you have and what’s driving it. Most approaches fall into three categories: medication, therapy, and physical rehabilitation.
Medication
For low desire in premenopausal women, the first FDA-approved drug was flibanserin, approved in August 2015. Unlike hormonal treatments, flibanserin works on brain chemistry. It increases dopamine and norepinephrine activity in parts of the brain involved in desire and arousal while reducing serotonin’s inhibitory effect. It is taken daily and is specifically indicated for women whose low desire is not explained by relationship problems, medication side effects, or another medical or psychiatric condition.
A second option, bremelanotide, works through a different pathway and is taken as needed rather than daily. For postmenopausal women, vaginal estrogen or other hormone-based therapies can address the tissue changes that cause dryness and pain.
Therapy and Counseling
Because psychological factors are so central to FSD, therapy is often part of the treatment plan. Cognitive behavioral approaches can help address performance anxiety, negative thought patterns around sex, and the effects of past trauma. For sexual pain disorders involving involuntary muscle tightening, exposure-based therapy using progressively larger vaginal dilators is a standard approach, since the muscle contraction is considered a conditioned response to fear.
Pelvic Floor Physical Therapy
The pelvic floor functions as what researchers call an “emotional organ,” meaning it reflexively tightens in response to anxiety and stress. Pelvic floor physical therapy teaches you to identify and relax these muscles, and it is particularly effective for pain-related FSD. It is often combined with dilator therapy and counseling for the best results.
Why It Often Goes Untreated
Despite affecting a large percentage of women, FSD is frequently underdiagnosed. Many women do not raise sexual concerns with their doctors, and many clinicians do not routinely ask. The condition also carries a layer of complexity that simple screening misses: relationship context, cultural expectations, religious upbringing, life stage stressors like divorce or caregiving, and even practical constraints like lack of privacy or mismatched work schedules can all play a role. Effective treatment usually requires looking at the full picture, not just prescribing a pill, which is why a combination of medical, psychological, and physical approaches tends to produce the best outcomes.